Electro-Acupuncture Tested in Adults With Obesity and Insulin Resistance
Tests electro-acupuncture against sham acupuncture in adults with obesity and insulin resistance.
Plain-language title generated from the registry record
Registry title: Electro-Acupuncture for Obese Patients With Insulin Resistance
Key facts
- Where
- Singapore, SingaporeSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 21 and 65 years old?
Source: NCT06609200, who can take part
Where in Singapore
- Nanyang Technological University Traditional Chinese Medicine ClinicSingapore, SingaporeTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Nanyang Technological University
- Trial code
- NCT06609200
- Record updated
- 9 April 2026
- Original description
This clinical trial aims to evaluate the efficacy and safety of electro-acupuncture for obese patients with insulin resistance. 60 participants will be randomized and allocated to either the electro-acupuncture arm or the sham acupuncture arm.Read full original descriptionShow less
Electro-acupuncture for the Obese Patient With Insulin Resistance: a Randomized Sham-controlled Clinical Trial
This clinical trial aims to evaluate the efficacy and safety of electro-acupuncture for obese patients with insulin resistance. 60 participants will be randomized and allocated to either the electro-acupuncture arm or the sham acupuncture arm.
Inclusion: Men and women aged between 21 and 65 years old; BMI ≥ 25 kg/m2; HOMA-IR ≥ 2.14, (HOMA-IR = fasting insulin (ųU/mL)* fasting glucose (mmol/L)/22.5); Not receiving any other weight control measures or any medical and/or drug history in the last 3 months.
Exclusion: Treating with drugs that may affect insulin sensitivity; Changes 10% of usual body weight in the previous 6 months weight; Diabetes mellitus; Endocrine diseases, including thyroid disorder, pituitary disorder, sex gland disorder, etc; Heart diseases, including arrhythmia, heart failure, and myocardial infarction, participants with pacemakers; Allergy and immunology diseases; Bleeding tendency; Stroke or unable to exercise; Pregnant or lactating women; Impaired hepatic or renal function.